ORIC Pharmaceuticals, Inc. (ORIC)

NASDAQ: ORIC · Real-Time Price · USD

5.70

-0.45 (-7.25%)

Mar 31, 2025, 1:29 PM EDT - Market open

ORIC Pharmaceuticals Employees

ORIC Pharmaceuticals had 115 employees as of December 31, 2024. The number of employees increased by 15 or 15.00% compared to the previous year.

Employees

115

Change (1Y)

15

Growth (1Y)

15.00%

Revenue / Employee

n/a

Profits / Employee

-$1,111,713

Market Cap

404.50M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	115	15	15.00%
Dec 31, 2023	100	14	16.28%
Dec 31, 2022	86	8	10.26%
Dec 31, 2021	78	17	27.87%
Dec 31, 2020	61	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

ORIC News

5 days ago - ORIC® Pharmaceuticals Announces ORIC-944 Preclinical Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
23 days ago - ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
4 weeks ago - ORIC® Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones - GlobeNewsWire
5 weeks ago - ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates - GlobeNewsWire
2 months ago - ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
2 months ago - ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones - GlobeNewsWire
2 months ago - ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
3 months ago - ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire